Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Sarah A. Ackroyd"'
Autor:
Rayne Peerenboom, Sarah A. Ackroyd, Cecilia Chang, Elena Diaz Moore, Tilley Jenkins Vogel, Melissa H. Lippitt, Gustavo Rodriguez, Carolyn V. Kirschner
Publikováno v:
Gynecologic Oncology Reports, Vol 41, Iss , Pp 101011- (2022)
The purpose of this study was to characterize survivorship concerns and survivorship program preferences among gynecologic cancer survivors. Women treated for gynecologic malignancy at our cancer center were surveyed from 1/2019 to 10/2020 on concern
Externí odkaz:
https://doaj.org/article/9226cacb9eb748a7b6bf27ea9f180773
Publikováno v:
Gynecologic Oncology Reports, Vol 41, Iss , Pp 100986- (2022)
Objective: To describe the use of telemedicine in gynecologic oncology and identify patient characteristics associated with telemedicine use during COVID-19. Methods: Single-institution retrospective chart review of patients with gynecologic cancer w
Externí odkaz:
https://doaj.org/article/5516f3a6516a45cdbe0f883bf4f3ea90
Autor:
Sarah A. Ackroyd, Lauren Goetsch, Jennifer Brown, Karen Houck, Congli Wang, Enrique Hernandez
Publikováno v:
Gynecologic Oncology Reports, Vol 28, Iss , Pp 109-115 (2019)
True primary mucinous ovarian carcinomas are rarer than originally thought and their clinical behavior and treatment response are different than more common epithelial ovarian carcinomas. Secondary ovarian neoplasms often mimic the clinical and histo
Externí odkaz:
https://doaj.org/article/891eeea346004742877f93606bb65dbf
Publikováno v:
Gynecol Oncol
Objective to examine the geographic distribution of gynecologic oncologists (GO) and assess if the GO workforce is meeting the demand for oncology services for patients with gynecologic cancers. Methods We identified GO by National Provider Identifie
Publikováno v:
Gynecologic Oncology. 162:249-255
Objective To determine the cost effectiveness of pembrolizumab/lenvatinib (P/L) versus standard-of-care carboplatin/paclitaxel (C/T) as first-line systemic therapy for patients with advanced/recurrent endometrial cancer. Methods We designed a Markov
Publikováno v:
Journal of Endometriosis and Pelvic Pain Disorders. 13:89-97
Introduction: To evaluate differences in surgical outcomes of minimally invasive hysterectomy performed for endometriosis between general gynecologists and gynecologic oncologists. Methods: Utilizing the 2016–2018 American College of Surgeons Natio
Publikováno v:
Journal of Endometriosis and Pelvic Pain Disorders. 13:83-88
Introduction: We aimed to evaluate surgical outcomes of hysterectomy for endometriosis performed by general obstetricians and gynecologists (OB/GYNs) based on surgical approach. Methods: Using the 2016–2018 National Surgical Quality Improvement Pro
Publikováno v:
Topics in Pain Management. 36:1-10
Autor:
Sarah A. Ackroyd, David Arguello, Pilar Ramos, Haider Mahdi, Adam ElNaggar, Ira Winer, Rob Holloway, Thomas Krivak, Nathaniel Jones, Valerie Galvan Turner, Thomas Herzog, Christina Chu, Jubilee Brown, Gina Mantia-Smaldone
Publikováno v:
Gynecologic oncology.
Advanced clear cell gynecologic malignancies remain among the most challenging diseases to manage. We evaluated ovarian and endometrial clear cell carcinoma (OCCC and ECCC) specimens using comprehensive sequencing technology to identify mutational ta
Autor:
Stephen C. Rubin, Sarah A. Ackroyd, Christina S. Chu, Gina Mantia-Smaldone, Karen Houck, Enrique Hernandez, Maureen E. Roberts
Publikováno v:
International Journal of Gynecologic Cancer. 30:1203-1209
ObjectiveThe aim of this study was to identify the rate of 30-day postoperative complications after the use of epidural in women undergoing hysterectomy for gynecologic malignancy. Secondary outcome was the impact of epidural on hospital length of st